The landscape of nuclear oncology is rapidly changing. The advent of molecular radionuclide theranostics, multidisciplinary tumor board decision making, artificial intelligence and radiomics interpretation of diagnostic imaging, evolution of pharmacogenomics prediction of tumor response, and regulatory requirements for prospective individual dosimetry are just some of the elements which are broadening the essence of physician responsibility. The burgeoning knowledge base essential for mastering the emergent technologies, and their profound effect on moral philosophic aspects of provision of cancer care, are challenging. The new relationship of the theranostic nuclear physician with respect to shared care of the individual patient, particularly with regard to transparency, accountability, and responsibility for targeted radionuclide diagnosis and therapy of cancer, will be explored in this update.

中文翻译：

---

负责任的放射性核素癌症护理

核肿瘤学的格局正在迅速变化。分子放射性核素治疗学的出现、多学科肿瘤委员会的决策、诊断成像的人工智能和放射组学解释、肿瘤反应的药物基因组学预测的演变以及前瞻性个体剂量学的监管要求只是拓宽医师本质的一些要素责任。掌握新兴技术所必需的新兴知识库及其对提供癌症护理的道德哲学方面的深远影响具有挑战性。治疗诊断核医师在个体患者共享护理方面的新关系，特别是在透明度、问责制、